These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37231492)

  • 1. Whole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment.
    Nurchis MC; Altamura G; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Garlasco J; Tartaglia M; Dallapiccola B; Damiani G
    Arch Public Health; 2023 May; 81(1):93. PubMed ID: 37231492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
    Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
    Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
    Clark MM; Stark Z; Farnaes L; Tan TY; White SM; Dimmock D; Kingsmore SF
    NPJ Genom Med; 2018; 3():16. PubMed ID: 30002876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
    JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
    Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
    Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
    Sabir AH; Morley E; Sheikh J; Calder AD; Beleza-Meireles A; Cheung MS; Cocca A; Jansson M; Lillis S; Patel Y; Yau S; Hall CM; Offiah AC; Irving M
    BMC Med Genomics; 2021 Jun; 14(1):148. PubMed ID: 34092239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
    Schwarze K; Buchanan J; Taylor JC; Wordsworth S
    Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational Aspects of the Implementation and Use of Whole Genome Sequencing and Whole Exome Sequencing in the Pediatric Population in Italy: Results of a Survey.
    Nurchis MC; Raspolini GM; Heidar Alizadeh A; Altamura G; Radio FC; Tartaglia M; Dallapiccola B; Damiani G
    J Pers Med; 2023 May; 13(6):. PubMed ID: 37373888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in neurometabolic diseases: The genetic role in the modern era.
    Tein I
    Epilepsy Behav; 2023 Aug; 145():109338. PubMed ID: 37453291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
    Soden SE; Saunders CJ; Willig LK; Farrow EG; Smith LD; Petrikin JE; LePichon JB; Miller NA; Thiffault I; Dinwiddie DL; Twist G; Noll A; Heese BA; Zellmer L; Atherton AM; Abdelmoity AT; Safina N; Nyp SS; Zuccarelli B; Larson IA; Modrcin A; Herd S; Creed M; Ye Z; Yuan X; Brodsky RA; Kingsmore SF
    Sci Transl Med; 2014 Dec; 6(265):265ra168. PubMed ID: 25473036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Damiani G
    Eur J Health Econ; 2024 Aug; 25(6):999-1011. PubMed ID: 37975990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
    Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
    J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
    Linthorst GE; Hollak CEM
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Singapore Undiagnosed Disease Program: Genomic Analysis aids Diagnosis and Clinical Management.
    Bhatia NS; Lim JY; Bonnard C; Kuan JL; Brett M; Wei H; Cham B; Chin H; Bosso-Lefevre C; Dharuman P; Escande-Beillard N; Devasia AG; Goh CYJ; Kam S; Liew WK; Liew WK; Lin G; Jain K; Ng AY; Subramanian D; Xie M; Tan YM; Tawari NR; Tiang Z; Ting TW; Tohari S; Tong CK; Lezhava A; Ng SB; Law HY; Venkatesh B; Tomar S; Sethi R; Tan G; Shanmugasundaram A; Goh DL; Lai PS; Lai A; Tan ES; Ng I; Reversades B; Tan EC; Foo R; Jamuar SS;
    Arch Dis Child; 2021 Jan; 106(1):31-37. PubMed ID: 32819910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield and treatment impact of whole-genome sequencing in paediatric neurological disorders.
    Lee HF; Chi CS; Tsai CR
    Dev Med Child Neurol; 2021 Aug; 63(8):934-938. PubMed ID: 33244750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.